[PHARMA] QoQ Cumulative Quarter Result on 31-Mar-2016 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
13-May-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
31-Mar-2016 [#1]
Profit Trend
QoQ- -78.13%
YoY- -42.19%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 2,189,022 1,606,206 1,090,991 559,195 2,189,312 1,509,162 984,749 69.91%
PBT 72,017 67,948 48,025 26,538 112,722 89,005 63,668 8.52%
Tax -26,158 -21,189 -13,914 -8,068 -28,138 -20,462 -15,100 43.99%
NP 45,859 46,759 34,111 18,470 84,584 68,543 48,568 -3.73%
-
NP to SH 45,599 46,435 33,374 18,379 84,044 67,982 48,011 -3.36%
-
Tax Rate 36.32% 31.18% 28.97% 30.40% 24.96% 22.99% 23.72% -
Total Cost 2,143,163 1,559,447 1,056,880 540,725 2,104,728 1,440,619 936,181 73.26%
-
Net Worth 531,169 530,907 524,041 515,906 529,482 534,070 527,991 0.39%
Dividend
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Div 41,457 33,667 23,302 10,354 77,674 59,542 36,234 9.34%
Div Payout % 90.92% 72.50% 69.82% 56.34% 92.42% 87.59% 75.47% -
Equity
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Net Worth 531,169 530,907 524,041 515,906 529,482 534,070 527,991 0.39%
NOSH 259,377 258,979 258,913 258,859 258,915 258,880 258,819 0.14%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin 2.09% 2.91% 3.13% 3.30% 3.86% 4.54% 4.93% -
ROE 8.58% 8.75% 6.37% 3.56% 15.87% 12.73% 9.09% -
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
RPS 844.83 620.21 421.37 216.02 845.57 582.96 380.48 69.78%
EPS 17.60 17.93 12.89 7.10 32.46 26.26 18.55 -3.42%
DPS 16.00 13.00 9.00 4.00 30.00 23.00 14.00 9.26%
NAPS 2.05 2.05 2.024 1.993 2.045 2.063 2.04 0.32%
Adjusted Per Share Value based on latest NOSH - 258,859
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
RPS 151.89 111.45 75.70 38.80 151.91 104.71 68.33 69.91%
EPS 3.16 3.22 2.32 1.28 5.83 4.72 3.33 -3.41%
DPS 2.88 2.34 1.62 0.72 5.39 4.13 2.51 9.55%
NAPS 0.3686 0.3684 0.3636 0.358 0.3674 0.3706 0.3663 0.41%
Price Multiplier on Financial Quarter End Date
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Date 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 -
Price 5.30 5.58 5.50 5.76 6.36 6.50 7.13 -
P/RPS 0.63 0.90 1.31 2.67 0.75 1.12 1.87 -51.42%
P/EPS 30.12 31.12 42.67 81.13 19.59 24.75 38.44 -14.94%
EY 3.32 3.21 2.34 1.23 5.10 4.04 2.60 17.61%
DY 3.02 2.33 1.64 0.69 4.72 3.54 1.96 33.22%
P/NAPS 2.59 2.72 2.72 2.89 3.11 3.15 3.50 -18.11%
Price Multiplier on Announcement Date
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Date 21/02/17 21/11/16 19/08/16 13/05/16 15/02/16 26/11/15 17/08/15 -
Price 5.12 5.70 5.62 5.60 6.19 6.50 5.65 -
P/RPS 0.61 0.92 1.33 2.59 0.73 1.12 1.48 -44.46%
P/EPS 29.09 31.79 43.60 78.87 19.07 24.75 30.46 -3.00%
EY 3.44 3.15 2.29 1.27 5.24 4.04 3.28 3.21%
DY 3.13 2.28 1.60 0.71 4.85 3.54 2.48 16.70%
P/NAPS 2.50 2.78 2.78 2.81 3.03 3.15 2.77 -6.57%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment